DADE Dade Behring Holdings (MM)

NEW YORK, Nov. 6 /PRNewswire/ -- QED International Associates Inc., administrator for the HealthShares(TM) Exchange-Traded Funds, a series of 20 underlying fund portfolios, today announced that effective at the opening of trading on Thursday November 8, 2007 Given Imaging, Ltd. (NASDAQ:GIVN) will replace Dade Behring Holdings, Inc. (NASDAQ:DADE), in the HealthShares(TM) Diagnostics Index, and Inverness Medical Innovations (AMEX:IMA) will replace DADE in the HealthShares(TM) Composite Index. Dade Behring is being acquired by Siemens, Inc. Companies included in the HealthShares(TM) Diagnostics Index engage in identification of the existence and extent of a disease, the visual localization of a disease by way of imaging, the selection of therapeutic agents appropriate for the disease wherever possible and the monitoring of disease progression/therapeutic efficacy. About HealthShares(TM) XShares Advisors LLC, a financial services company based in New York, is the creator of the HealthShares(TM) family of Exchange Traded Funds (ETFs). HealthShares(TM) ETFs are organized into therapeutic 'Verticals' and represent specific areas of the healthcare, life science and biotechnology industries. Each Vertical addresses a distinct sub-segment of healthcare, such as the diagnosis and treatment of specific therapeutic areas (e.g. cardiology, cancer, infectious disease, etc.) and the development of medical devices (e.g. orthopedic repair, cardio devices, etc.). Each ETF tracks an index of 22-25 stocks and offers institutional and individual investors a more precise financial instrument that leverages the potential of healthcare investing while mitigating the risks of single stock picking. For more information, visit the company's website at: http://www.healthsharesinc.com/. About QED International Associates QED International, based in New York, is a leading financial industry consulting firm specializing in quantitative modeling and the design, development and maintenance of indexes and Exchange Traded Funds. For more information, visit the company's website at http://www.qedinternational.com/ Contact Information For QED International: Ed Matluck, CEO Michael Carty, Senior Advisor Senior Vice President (212) 953-4058 DATASOURCE: QED International Associates Inc. CONTACT: Ed Matluck, CEO, or Michael Carty, Senior Advisor, Senior Vice President, +1-212-953-4058, Web site: http://www.healthsharesinc.com/ http://www.qedinternational.com/

Copyright